Mometasona Mede (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Mede, is a corticosteroid presented as a topical formulation for skin use. It is employed to treat inflammatory dermatoses such as psoriasis, eczema, atopic dermatitis and allergic skin reactions in adult and pediatric patients. Application is typically once or twice daily under medical supervision.

GNH USA supplies Mometasona Mede as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable cold‑chain logistics where required.

Mometasone furoate is a potent topical corticosteroid that reduces inflammation in various skin disorders.

Psoriasis: decreases plaque thickness, erythema and scaling, helping to restore a smoother skin appearance. Eczema: relieves itching, redness and inflammation, allowing the affected area to heal more quickly. Atopic dermatitis: controls flare‑ups, reduces scratching and improves skin barrier integrity in chronic cases. Allergic skin reactions: diminishes swelling, redness and discomfort caused by contact allergens or irritants.

Topical application of Mometasona Mede may be associated with local and systemic adverse reactions.

Common Side Effects: - Burning, stinging or mild irritation at the site of application. - Dryness or peeling of the treated skin. - Redness or mild erythema. - Itching unrelated to the underlying condition.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Development of telangiectasia (visible small blood vessels). - Local hypopigmentation or depigmentation. - Systemic corticosteroid effects such as adrenal suppression when large body areas are treated.

When using Mometasona Mede, follow these safety measures to minimize risks. - Apply to limited body surface: limit use to ≤10% of body surface area to reduce systemic absorption. - Avoid use on broken or infected skin: may increase irritation or infection risk. - Do not use under occlusive dressings unless directed: can enhance drug penetration. - Limit duration of continuous therapy: typically no longer than 2‑4 weeks without medical review. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Mometasona Mede may interact with other medications; consider the following.

Major Interactions (Avoid): - Concurrent systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Potent CYP3A4 inhibitors applied to the same area: may raise local drug concentration. - Live vaccines: topical steroids may diminish immune response at the application site.

Moderate Interactions (Monitor Closely): - Antifungal or antibacterial topical agents: potential for increased irritation. - Phototherapy (UVB): may increase risk of skin atrophy. - Other topical immunosuppressants (e.g., tacrolimus): additive immunosuppression.